Literature DB >> 1660829

A general topoisomerase I-dependent transcriptional repression in the stationary phase in yeast.

M Choder1.   

Abstract

This paper shows that in the yeast Saccharomyces cerevisiae the levels of most mRNAs decrease, in a temporally orchestrated manner, as cells approach and enter the stationary phase. The decreased level of mRNAs is primarily due to transcriptional repression because the overall rate of in vivo transcription by RNA polymerase II is similarly reduced in the stationary phase. The reduction in mRNA levels and the general transcriptional repression are both dependent on topoisomerase I (encoded by TOP1). Specifically, these two processes are much slower in top1 mutants, as their mRNA levels and transcriptional rate remain unchanged for a longer period of time in the stationary phase before they start to decrease. In contrast, the mRNA levels in the stationary phase are not affected by perturbation of topoisomerase II activity. TOP1-dependent repression operates even on HSP26 and SSA3, which have been shown previously to be transcriptionally induced in early stationary phase. Thus, their mRNA levels are high upon the entry of the cells into the stationary phase but gradually decrease, by a TOP1-dependent mechanism, later in the stationary phase. A minor population of mRNAs is not subjected to the TOP1-dependent regulation, as their levels do not change in stationary phase. The possible role of topoisomerase I in the general transcriptional repression is discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1660829     DOI: 10.1101/gad.5.12a.2315

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  58 in total

1.  Global control of histone modification by the anaphase-promoting complex.

Authors:  Vijay Ramaswamy; Jessica S Williams; Karen M Robinson; Richelle L Sopko; Michael C Schultz
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

2.  Rpb4p, a subunit of RNA polymerase II, mediates mRNA export during stress.

Authors:  Marganit Farago; Tal Nahari; Christopher Hammel; Charles N Cole; Mordechai Choder
Journal:  Mol Biol Cell       Date:  2003-07       Impact factor: 4.138

Review 3.  Staying alive: metabolic adaptations to quiescence.

Authors:  James R Valcourt; Johanna M S Lemons; Erin M Haley; Mina Kojima; Olukunle O Demuren; Hilary A Coller
Journal:  Cell Cycle       Date:  2012-05-01       Impact factor: 4.534

Review 4.  Transcriptional regulation in yeast during diauxic shift and stationary phase.

Authors:  Luciano Galdieri; Swati Mehrotra; Sean Yu; Ales Vancura
Journal:  OMICS       Date:  2010-09-23

5.  Separation of the transcriptional coactivator and antirepression functions of transcription factor IIA.

Authors:  D MA; I Olave; A Merino; D Reinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

6.  Eukaryotic translation initiation factor 4E-dependent translation is not essential for survival of starved yeast cells.

Authors:  I Paz; M Choder
Journal:  J Bacteriol       Date:  2001-08       Impact factor: 3.490

7.  The RNA polymerase II subunit Rpb4p mediates decay of a specific class of mRNAs.

Authors:  Rona Lotan; Vicky Goler Bar-On; Liat Harel-Sharvit; Lea Duek; Daniel Melamed; Mordechai Choder
Journal:  Genes Dev       Date:  2005-12-15       Impact factor: 11.361

8.  Topoisomerase I involvement in illegitimate recombination in Saccharomyces cerevisiae.

Authors:  J Zhu; R H Schiestl
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

9.  Mat formation in Saccharomyces cerevisiae requires nutrient and pH gradients.

Authors:  Todd B Reynolds; An Jansen; Xin Peng; Gerald R Fink
Journal:  Eukaryot Cell       Date:  2007-10-19

10.  The yeast type I topoisomerase Top3 interacts with Sgs1, a DNA helicase homolog: a potential eukaryotic reverse gyrase.

Authors:  S Gangloff; J P McDonald; C Bendixen; L Arthur; R Rothstein
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.